Edition:
United Kingdom

Novozymes A/S (NZYMb.CO)

NZYMb.CO on Copenhagen Stock Exchange

317.90DKK
23 Feb 2018
Change (% chg)

kr.-1.10 (-0.34%)
Prev Close
kr.319.00
Open
kr.319.80
Day's High
kr.321.40
Day's Low
kr.314.80
Volume
373,934
Avg. Vol
508,230
52-wk High
kr.360.70
52-wk Low
kr.264.10

Chart for

About

Novozymes A/S is a Denmark-based biotechnology company engaged in the production and sale of industrial enzymes, microorganisms and biopharmaceutical ingredients. The Company operates in four geographical regions: Europe, Middle East & Africa (including Denmark), North America, Asia Pacific and Latin America. It develops and... (more)

Overall

Beta: 1.21
Market Cap(Mil.): kr.83,115.62
Shares Outstanding(Mil.): 251.26
Dividend: 4.00
Yield (%): 1.21

Financials

  Industry Sector
P/E (TTM): -- 18.71 16.60
EPS (TTM): -- -- --
ROI: -- 18.43 10.66
ROE: -- 25.76 14.30

UPDATE 1-Novozymes results miss estimates as household care drags

Feb 7 Danish enzymes maker Novozymes reported fourth-quarter results below market expectations on Wednesday as organic growth at its biggest division, Household Care, declined.

07 Feb 2018

BRIEF-Novozymes Appoints Prisca Havranek-Kosicek New CFO

* PRISCA HAVRANEK-KOSICEK NEW CFO Source text for Eikon: Further company coverage: (Gdynia Newsroom)

20 Dec 2017

MOVES-Pandora poaches communications director from Novozymes

COPENHAGEN, Dec 6 Danish jewellery maker Pandora said in a statement on Wednesday:

06 Dec 2017

BRIEF-Novozymes CEO Sells 50,000 Of Own Shares

* CEO SELLS 50.000 OF OWN SHARES IN COMPANY FOR A TOTAL VALUE OF DKK 17.2 MILLION Source text for Eikon: Further company coverage: (Gdynia Newsroom)

29 Nov 2017

BRIEF-Novozymes completes share buyback program

* ‍NOVOZYMES HAS NOW COMPLETED ANNOUNCED SHARE BUYBACK PROGRAM OF B SHARES WORTH UP TO DKK 2 BILLION IN TOTAL DURING 2017​ Source text for Eikon: Further company coverage: (Gdynia Newsroom)

10 Nov 2017

Novozymes shares surge as bioenergy tops expectations

COPENHAGEN, Oct 25 Denmark's Novozymes reported third-quarter sales and earnings ahead of forecasts on Wednesday and raised its outlook as more powerful enzymes products drove demand from ethanol makers, sending its shares up six percent to a two-year high.

25 Oct 2017

BRIEF-Novozymes Q3 EBIT above expectations at DKK 1.06 bln

* NOVOZYMES - STILL SOME UNCERTAINTY REGARDING AGRICULTURE-RELATED MARKETS IN Q4‍​

25 Oct 2017

Earnings vs. Estimates